Close Menu

NEW YORK (GenomeWeb) – Interpace Diagnostics announced today that it has priced a public offering that aims to raise $13.7 million in gross proceeds.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.